Recombinant Arabidopsis thaliana ALS Protein (Yeast)，His

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by the degeneration of motor neurons, leading to muscle weakness and atrophy. The underlying mechanisms of ALS are not yet fully understood, but genetic factors, protein aggregation, and neuroinflammation have been implicated in its pathogenesis. Recent research has focused on the role of protein aggregates, particularly the misfolded forms of proteins such as TDP-43 and FUS, which are commonly found in the affected neurons of ALS patients. The study of recombinant proteins has emerged as a vital tool in understanding the molecular basis of ALS. By producing and analyzing these proteins in vitro, researchers can investigate their structural properties, aggregation tendencies, and toxic effects on neuronal cells. This research not only aids in elucidating the pathophysiological processes of ALS but also paves the way for the development of potential therapeutic strategies aimed at preventing protein misfolding and promoting cellular resilience. Advances in techniques such as cryo-electron microscopy and high-throughput screening are facilitating deeper insights into protein interactions and aggregation pathways, which may ultimately lead to novel treatment options for ALS. Understanding the role of ALS-related recombinant proteins is crucial for uncovering the disease mechanisms and identifying targets for drug development.